NGS Testing & Participation And Funding In Clinical Trials with Dr. Alexander Drilon

Dr. Jack West is joined by Dr. Alexander Drilon to discuss the challenge of NGS testing and increased participation and funding in lung cancer clinical trials. Dr. Drilon is Associate Attending Physician and Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center in New York. Dr. Drilon has been at the forefront of development of many novel targeted therapies for some of the newest biomarker-driven therapies for advanced non-small cell.